Open Label Study to Evaluate Safety and Efficacy of 2 Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Memorial Sloan-Kettering Cancer Center, New York

Weill Cornell Medical College, New York

Penn State Milton S. Hershey Medical Center, Hershey

Hospital of the University of Pennsylvania, Philadelphia

University of Maryland Greenebaum Cancer Center, Baltimore

John Hopkins University, Baltimore

Medical University of South Carolina, Hollings Cancer Center, Charleston

Hôpital Haut Lévêque, Pessac

Vanderbilt University, Vanderbilt Ingram Cancer Center, Nashville

CHU de Grenoble, Grenoble

"Universitaria Policlinico S. Orsola Malpighi, Institute of Hemtology L. & A. Seragnoli", Bologna

CHU d'Angers, Angers

University of Minnesota, Minneapolis

Mayo Clinic, Rochester

Northwestern University, Chicago

University of Chicago, Chicago

UT Southwestern Medical Center, Simmons Cancer Center, Dallas

Hôpital Saint Antoine, Paris

MD Anderson, Houston

UCLA School of Medicine, Los Angeles

Fred Hutchinson Cancer Research Center, Seattle

Tufts University School of Medicine-Tufts Medical Center, Boston

Hackensack University Medical Center, Hackensack

Nottingham University Hospitals, Nottingham